Fortis & SRL Diagnostics contribute Rs 6 crore to IIT Madras for R&D initiatives

The Brain Centre, launched in March 2022 at IIT-M focuses on mapping the human brain at cellular and connectivity levels and developing innovative technological solutions

0
71
Biovoice News COVID-19
New Delhi: The Fortis and SRL Group of Companies, leading integrated healthcare services providers in India, contributed a sum of nearly INR 6 crores in FY‘23 to the Sudha Gopalakrishnan Brain Centre at IIT, Madras, as a part of their Corporate Social Responsibility (CSR) mandate.
The Brain Centre, launched in March 2022 at IIT-M focuses on mapping the human brain at cellular and connectivity levels and developing innovative technological solutions that will provide extraordinary and significant insights into the brain’s neural networks and take the country to the world’s centre stage.
Fortis and SRL Group aspire to advance healthcare technology through its social development initiatives to improve community health outcomes while focusing on the sustainable development of society. Contribution to the Brain Centre is a potent way of fostering and promoting research and development (& innovation) to benefit society’s current and future generations.
“As a donor to the Sudha Gopalakrishnan Brain Centre, we are delighted to support their ground-breaking brain mapping project for the advancement of modern medicine. This pioneering research perfectly aligns with our commitment to promote and fund innovation in medical sciences. As a healthcare services provider, our aim in this collaboration is to foster revolutionary solutions that will pave the way for the future of healthcare innovation for decades to come.” said Dr Ashutosh Raghuvanshi, Managing Director and Chief Executive Officer of Fortis Healthcare.
“At SRL, we remain steadfast in our objective to enhance and uphold human health and well-being, and we believe that supporting pioneering research institutions like the Sudha Gopalakrishnan Brain Centre is key to achieving this goal. We take immense pride in being a part of the progress of the global healthcare industry by contributing to the revolutionary research that will pave the way for the future of healthcare” added Anand K., Chief Executive Officer of SRL Diagnostics.
Fortis & SRL are committed to improving and preserving people’s health and well-being, and we believe funding cutting-edge research centres like the Sudha Gopalakrishnan Brain Centre is essential to achieving this. As a healthcare services provider, our goal in this cooperation is to generate new solutions that will pave the way for the future of healthcare innovation for decades to come.
Mr Kris Gopalakrishnan, Co-founder of Infosys and Distinguished Alumnus of IIT-M, said “The trust and confidence demonstrated by the Fortis Group of Companies towards the Brain Centre through their generous contribution is invaluable. It displays the exemplary commitment of the Company to support cutting-edge research in the country. I hope that this contribution will inspire other organizations to come forward to support such research efforts at IIT Madras.”
Professor Mohanasankar Sivaprakasam who heads the IIT Madras Brain Centre said, “This support by Fortis Group of Companies is timely and essential towards achieving the vision of the Brain Centre of becoming a globally leading brain research Centre that produces highly sought after human brain data and technology tools.”